Sol-Gel Technologies (SLGL) Retained Earnings (2016 - 2026)

Sol-Gel Technologies (SLGL) reported Retained Earnings of -$240.7 million for Q1 2026, little changed year-over-year from -$241.8 million in Q1 2025, and down 1.57% quarter-over-quarter from -$237.0 million in Q4 2025.

Sol-Gel Technologies (SLGL) Retained Earnings (2016 - 2026) Analysis & Trends

Sol-Gel Technologies (SLGL) has 11 years of Retained Earnings data on file, last reported at -$240.7 million in Q1 2026.

  • Retained Earnings for Q1 2026 came in at -$240.7 million, changed 0.44% year-over-year; the trailing twelve-month figure through Mar 2026 was -$240.7 million (changed 0.44% YoY), and the FY2025 annual result was -$237.0 million, down 2.65% from the prior year.
  • Retained Earnings declined to -$240.7 million in Q1 2026 per SLGL's latest filing, from -$237.0 million in the prior quarter.
  • Over five years, Retained Earnings peaked at -$183.7 million in Q1 2022 and troughed at -$240.7 million in Q1 2026.
  • A 5-year average of -$216.7 million and a median of -$224.7 million in 2024 frame the typical range for Retained Earnings.
  • The sharpest annual moves came in 2022 and 2023: Retained Earnings advanced 4.96% in 2022, then declined 15.05% in 2023.
  • A 5-year view of Retained Earnings shows it stood at -$193.1 million in 2022, then slipped by 14.11% to -$220.3 million in 2023, then dropped by 4.8% to -$230.9 million in 2024, then retreated by 2.65% to -$237.0 million in 2025, then dropped by 1.57% to -$240.7 million in 2026.
  • Business Quant data shows SLGL's Retained Earnings at -$240.7 million in Q1 2026, -$237.0 million in Q4 2025, and -$234.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -153.89 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -211.85 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 1.00 Bn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 130.89 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -279.00 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -1.88
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 14.59 Bn
9 Abivax 91.96 Bn 91.96 Bn - -838.07 Mn
10 Sol-Gel Technologies 207.80 Mn 197.67 Mn - -240.74 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -240.74 Mn
Dec 31, 2025 -237.01 Mn
Sep 30, 2025 -234.02 Mn
Jun 30, 2025 -228.08 Mn
Mar 31, 2025 -239.69 Mn
Dec 31, 2024 -230.88 Mn
Sep 30, 2024 -225.04 Mn
Jun 30, 2024 -224.67 Mn
Mar 31, 2024 -226.65 Mn
Dec 31, 2023 -220.30 Mn
Sep 30, 2023 -215.47 Mn
Jun 30, 2023 -209.76 Mn
Mar 31, 2023 -203.33 Mn
Dec 31, 2022 -193.07 Mn
Sep 30, 2022 -187.28 Mn
Jun 30, 2022 -183.87 Mn
Mar 31, 2022 -183.74 Mn
Dec 31, 2021 -178.14 Mn
Sep 30, 2021 -192.17 Mn
Jun 30, 2021 -193.46 Mn